IBM Claims a Milestone with First Simulation Results from BlueGene/L, Blue Matter Software | GenomeWeb

IBM has published its first protein simulation study using BlueGene/L — the first proof that its new supercomputer can meet the demands of computationally demanding life science research problems.

“This is a big achievement for us,” said Ajay Royyuru, who heads the Computational Biology Center at IBM Research. “In a sense, this is the first science output that we have in using BlueGene in an area that we had targeted all along for exactly this purpose.”

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nucleic Acids Research this week: ProTraits includes genetic, phenotypic data on bacteria, archaea; Candida albicans assembly 22; and more.

The Wall Street Journal reports that researchers are looking beyond Cas9 for CRISPR editing.

Familial DNA searches in criminal cases are winning over some critics, the Los Angeles Times reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.